End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.05 SAR | -0.73% | -2.85% | +2.56% |
Mar. 28 | Basic Chemical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 25 | Basic Chemical Industries Posts Lower FY23 Net Profit; Revenue Rises | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 607.8 | 659.4 | 917.1 | 1,101 | 926.8 | 913 |
Enterprise Value (EV) 1 | 500.9 | 597.9 | 937.5 | 1,330 | 1,255 | 1,147 |
P/E ratio | 12.2 x | 16 x | 23.7 x | 32 x | 22.9 x | 165 x |
Yield | - | 4.17% | - | - | 2.97% | - |
Capitalization / Revenue | 1 x | 1.23 x | 1.83 x | 2.15 x | 1.37 x | 1.23 x |
EV / Revenue | 0.83 x | 1.12 x | 1.87 x | 2.59 x | 1.86 x | 1.55 x |
EV / EBITDA | 4.58 x | 6.18 x | 9.56 x | 14.4 x | 10.7 x | 9.93 x |
EV / FCF | -5.66 x | -18.5 x | -34.7 x | -7.68 x | -17.1 x | 17.8 x |
FCF Yield | -17.7% | -5.4% | -2.88% | -13% | -5.83% | 5.63% |
Price to Book | 1.2 x | 1.2 x | 1.64 x | 1.93 x | 1.51 x | 1.54 x |
Nbr of stocks (in thousands) | 27,500 | 27,500 | 27,500 | 27,500 | 27,500 | 27,500 |
Reference price 2 | 22.10 | 23.98 | 33.35 | 40.05 | 33.70 | 33.20 |
Announcement Date | 3/26/19 | 3/26/20 | 4/1/21 | 4/3/22 | 3/29/23 | 3/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 605.2 | 534.6 | 500.2 | 513.4 | 674.7 | 741.1 |
EBITDA 1 | 109.3 | 96.68 | 98.04 | 92.13 | 117.1 | 115.5 |
EBIT 1 | 82.15 | 69.2 | 70.91 | 74.39 | 94.99 | 76.7 |
Operating Margin | 13.57% | 12.94% | 14.18% | 14.49% | 14.08% | 10.35% |
Earnings before Tax (EBT) 1 | 82.88 | 69.04 | 67.39 | 68.8 | 80.03 | 55.53 |
Net income 1 | 49.67 | 41.22 | 38.62 | 34.37 | 40.43 | 5.518 |
Net margin | 8.21% | 7.71% | 7.72% | 6.69% | 5.99% | 0.74% |
EPS 2 | 1.806 | 1.499 | 1.405 | 1.250 | 1.470 | 0.2007 |
Free Cash Flow 1 | -88.46 | -32.28 | -27 | -173.2 | -73.23 | 64.53 |
FCF margin | -14.62% | -6.04% | -5.4% | -33.74% | -10.85% | 8.71% |
FCF Conversion (EBITDA) | - | - | - | - | - | 55.88% |
FCF Conversion (Net income) | - | - | - | - | - | 1,169.47% |
Dividend per Share | - | 1.000 | - | - | 1.000 | - |
Announcement Date | 3/26/19 | 3/26/20 | 4/1/21 | 4/3/22 | 3/29/23 | 3/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 20.4 | 229 | 328 | 234 |
Net Cash position 1 | 107 | 61.6 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.2077 x | 2.486 x | 2.806 x | 2.027 x |
Free Cash Flow 1 | -88.5 | -32.3 | -27 | -173 | -73.2 | 64.5 |
ROE (net income / shareholders' equity) | 12.2% | 9.84% | 9.37% | 9.38% | 10.7% | 6.44% |
ROA (Net income/ Total Assets) | 7.48% | 5.97% | 5.47% | 4.79% | 5.09% | 3.82% |
Assets 1 | 664.4 | 690.5 | 706.1 | 716.9 | 793.9 | 144.5 |
Book Value Per Share 2 | 18.40 | 20.00 | 20.40 | 20.70 | 22.30 | 21.50 |
Cash Flow per Share 2 | 3.890 | 2.900 | 3.070 | 2.600 | 2.250 | 3.260 |
Capex 1 | 165 | 117 | 171 | 198 | 122 | 19.5 |
Capex / Sales | 27.28% | 21.94% | 34.12% | 38.62% | 18.08% | 2.63% |
Announcement Date | 3/26/19 | 3/26/20 | 4/1/21 | 4/3/22 | 3/29/23 | 3/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+2.56% | 250M | |
-0.19% | 74.89B | |
+0.09% | 46.52B | |
-4.19% | 30.82B | |
+9.85% | 18.19B | |
-10.05% | 11.54B | |
+6.39% | 11.24B | |
-8.09% | 9.73B | |
+2.79% | 9.4B | |
+6.35% | 9.37B |
- Stock Market
- Equities
- 1210 Stock
- Financials Basic Chemical Industries Company